| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |